Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation, FDII, Amount
Effective Income Tax Rate Reconciliation, FDII, Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation, fdii, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation, FDII, amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation, FDII, amount of $5.27M in Q4 2024.
- How has Ionis Pharmaceuticals's effective income tax rate reconciliation, FDII, amount changed year-over-year?
- Ionis Pharmaceuticals's effective income tax rate reconciliation, FDII, amount increased by 181.2% year-over-year, from $1.87M to $5.27M.
- What does effective income tax rate reconciliation, FDII, amount mean?
- The tax savings amount derived from the FDII deduction for foreign-earned income.
- How do you interpret effective income tax rate reconciliation, FDII, amount?
- Higher amounts signal successful international expansion and effective utilization of tax incentives for intellectual property.
- How does effective income tax rate reconciliation, FDII, amount compare across companies?
- Relevant for companies with significant international revenue streams and intellectual property.